EMERGENCE-BIO - Emergence et maturation de projets de biotechnologie et de Technologie pour la santé à fort potentiel de valorisation
Thérapie antithrombotique basée sur l'utilisation d'anticorps monoclonaux ciblant le facteur Willebrand – ThrombAWill
Project coordination
Cécile DENIS (Organisme de recherche)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
Help of the ANR 136,614 euros
Beginning and duration of the scientific project:
- 24 Months
